Clone:
REA950
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC
Alternative names:
HLAA

Extended validation for HLA-A3 Antibody, anti-human, REAfinity™

Specificity

Epitope competition
In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.
Other clonesOverlap in epitope recognition with REA950
GAP.A3++
Cells were incubated with an excess of purified unconjugated HLA-A3 (REA950) antibody followed by staining with fluorochrome-conjugated antibodies of other known clones against the same marker. Based on the fluorescence signal obtained, the clones were identified as recognizing completely overlapping (++), partially overlapping (+), or completely different epitopes (-) of the marker.

Sensitivity

Performance comparison
Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.
View details
Flow cytometric comparison of different clones for HLA-A3. Human peripheral blood mononuclear cells (PBMCs) after erythrocyte lysis from HLA-A3+ und HLA-A3– donors were stained with HLA-A3 antibodies and with a suitable counterstaining. As a control, HLA-A3 antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
View details
Flow cytometric comparison of different clones for HLA-A3. Human peripheral blood mononuclear cells (PBMCs) after erythrocyte lysis from HLA-A3+ und HLA-A3– donors were stained with HLA-A3 antibodies and with a suitable counterstaining. As a control, HLA-A3 antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
View details
Flow cytometric comparison of different clones for HLA-A3. Human peripheral blood mononuclear cells (PBMCs) after erythrocyte lysis from HLA-A3+ und HLA-A3– donors were stained with HLA-A3 antibodies and with a suitable counterstaining. As a control, HLA-A3 antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
Flow cytometric comparison of different clones for HLA-A3. Human peripheral blood mononuclear cells (PBMCs) after erythrocyte lysis from HLA-A3+ und HLA-A3– donors were stained with HLA-A3 antibodies and with a suitable counterstaining. As a control, HLA-A3 antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
Fixation data
To provide an indication on how an antibody performs after fixation of cells, in-house data on staining results before and after fixation with 3.7% formaldehyde using Miltenyi Biotec antibodies are provided. Different experimental settings may lead to different results.
No fixation
Post fixation
View details
Comparison of staining pattern on non-fixed and fixed cells using HLA-A3 (REA950). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.
View details
Comparison of staining pattern on non-fixed and fixed cells using HLA-A3 (REA950). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.
Comparison of staining pattern on non-fixed and fixed cells using HLA-A3 (REA950). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.

Specifications for HLA-A3 Antibody, anti-human, REAfinity™

Overview

Clone REA950 recognizes the human major histocompatibility complex (MHC) class I molecule HLA-A3, a heterodimer belonging to the HLA-A family and consisting of two subtypes, A3.1 and A3.2. HLA-A has a heavy chain (anchored in the membrane) and a light chain (beta-2 microglobulin). MHC class I molecules are expressed on nearly all nucleated cells and present small intracellular peptides on the cell surface to the immune system. The peptids are recognized by circulating CD8
+
cytotoxic T lymphocytes.
Additional information: Clone REA950 displays negligible binding to Fc receptors.

Alternative names

HLAA

Detailed product information

Technical specifications

CloneREA950
Clonalitymonoclonal
Isotyperecombinant human IgG1
Isotype controlREA Control Antibody (S), human IgG1
Hosthuman cell line
Type of antibodyPrimary antibodies, Recombinant antibodies
Specieshuman
AntigenHLA-A3
Alternative names of antigenHLAA
Molecular mass of antigen [kDa]38
Distribution of antigenany cell type
Entrez Gene ID3105
RRIDAB_2727169, AB_2727191, AB_2727170, AB_2727192, AB_2727171, AB_2727261, AB_2727219, AB_2727193, AB_2727172, AB_2727194, AB_2727173, AB_2928675, AB_2928674, AB_2727190

Resources for HLA-A3 Antibody, anti-human, REAfinity™

Certificates

Please follow this
link
to search for Certificates of Analysis (CoA) by lot number.

References for HLA-A3 Antibody, anti-human, REAfinity™

Publications

  1. Jelachich, M. L. et al. (1988) Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule. J Immunol 141(4): 1108-1113

Related products for
HLA-A3 Antibody, anti-human, REAfinity™

2 products available

Seems like you are coming from USA!
Do you want to visit our website in your country?